They work through different mechanisms that complement each other, which is why most recovery-peptide clinics prescribe them as a stack rather than asking patients to choose
In laboratory conditions, BPC-157 remains stable in acidic environments, supporting its proposed gut-protective role
This releases platelet-derived growth factor (PDGF) , vascular endothelial growth factor (VEGF) , epidermal growth factor (EGF) , and fibroblast growth factor (FGF)
In 1997, Sikiri's own lab reported that BPC-157 did something in the brain it blunted the effects of amphetamine, blocking "the stereotypy produced acutely by amphetamine" [10]
At 15 mg/mL concentration (30 mg vial + 2 mL bac water), the 12 mg dose draws 80 units on a U-100 syringe